Cardiovascular Drugs And Therapy

Cardiovascular Drugs And Therapy英文簡介

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

Cardiovascular Drugs And Therapy中文簡介

《Cardiovascular Drugs And Therapy》是一本由SPRINGER出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于1987年，刊期Bimonthly，該刊已被國際權威數(shù)據(jù)庫SCI、SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：心臟和心血管系統(tǒng) 3區(qū)；藥學 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q2。該刊發(fā)文范圍涵蓋心臟和心血管系統(tǒng)等領域，旨在及時、準確、全面地報道國內(nèi)外心臟和心血管系統(tǒng)工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為3.947，平均審稿速度平均4.5月。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng) PHARMACOLOGY & PHARMACY 藥學	3區(qū) 3區(qū)	否	否

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q2	PHARMACOLOGY & PHARMACY	Q2	3.947
	CARDIAC & CARDIOVASCULAR SYSTEMS	Q2

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
3.947	63	23.82%	67.53%	未開放	平均4.5月

IF值(影響因子)趨勢圖